Fallas Jennifer, Salmon Isabelle, Maris Calliope, Gómez Galdón María, D'Haene Nicky, Noël Jean-Christophe, Catteau Xavier
Department of Pathology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels.
CurePath Laboratory, Jumet, Belgium.
Int J Gynecol Pathol. 2025 Sep 1;44(5):461-465. doi: 10.1097/PGP.0000000000001073. Epub 2025 Jan 28.
Primary retroperitoneal mucinous carcinomas (PRMCa) are exceedingly rare and poorly understood neoplasms, with <80 cases documented in the medical literature and molecular profiling hardly ever performed. Recent theories suggest that PRMCa might develop from mature cystic teratomas or Brenner tumors, mirroring their ovarian counterparts. However, only 2 cases of primary retroperitoneal mucinous tumors associated with teratoma have been reported in the literature to support this idea. In this paper, we detail an exceptional case: a 66-yr-old woman with ovarian metastases stemming from a PRMCa that originated in a mature cystic teratoma. The patient initially presented with a long-standing cystic mass in the retroperitoneum, diagnosed as a mucinous carcinoma after surgical removal. Following initial resection, the patient experienced rapid metastatic progression requiring aggressive treatment. Interestingly, the later ovarian metastases exhibited the full spectrum of architectural complexity observed in the initial lesion. This "maturation phenomenon," frequently observed in ovarian metastases of mucinous tumors, remains enigmatic. Molecular analysis revealed a KRAS mutation along with an ERBB3 mutation, making it the first instance of ERBB3 mutation being documented in this specific entity. This case underscores the importance of thorough data collection and continued research to improve our understanding of these rare tumors.
原发性腹膜后黏液性癌(PRMCa)是极为罕见且了解甚少的肿瘤,医学文献中记录的病例不足80例,且几乎从未进行过分子剖析。最近的理论表明,PRMCa可能由成熟囊性畸胎瘤或 Brenner 瘤发展而来,类似于它们在卵巢中的对应物。然而,文献中仅报道了2例与畸胎瘤相关的原发性腹膜后黏液性肿瘤来支持这一观点。在本文中,我们详细介绍了一个特殊病例:一名66岁女性,其卵巢转移瘤源于起源于成熟囊性畸胎瘤的PRMCa。患者最初表现为腹膜后长期存在的囊性肿块,手术切除后诊断为黏液性癌。初次切除后,患者出现快速转移进展,需要积极治疗。有趣的是,后来的卵巢转移瘤表现出与初始病变中观察到的相同的全部结构复杂性。这种“成熟现象”在黏液性肿瘤的卵巢转移中经常观察到,仍然是个谜。分子分析显示存在KRAS突变以及ERBB3突变,这使其成为该特定实体中首次记录到ERBB3突变的病例。该病例强调了全面数据收集和持续研究对于增进我们对这些罕见肿瘤理解的重要性。